Intrinsic Value of S&P & Nasdaq Contact Us

Avadel Pharmaceuticals plc AVDL NASDAQ

NASDAQ Global Market • Healthcare • Drug Manufacturers - Specialty & Generic • IE • USD

SharesGrow Score
38/100
0/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$20.00
-7.6%

Avadel Pharmaceuticals plc (AVDL) — Analyst outlook / Analyst consensus target is. Based on 14 analyst ratings, the consensus is bullish — 8 Buy, 6 Hold.

The consensus price target is $20.00 (low: $19.00, high: $21.00), representing a downside of 7.6% from the current price $21.64.

AVDL Stock — 12-Month Price Forecast

$20.00
▼ -7.58% Downside
Average Price Target
Based on 14 Wall Street analysts offering 12-month price targets for Avadel Pharmaceuticals plc, the average price target is $20.00, with a high forecast of $21.00, and a low forecast of $19.00.
The average price target represents a -7.58% change from the last price of $21.64.
Highest Price Target
$21.00
Average Price Target
$20.00
Lowest Price Target
$19.00

AVDL Analyst Ratings

Buy
14
Ratings
8 Buy
6 Hold
Based on 14 analysts giving stock ratings to Avadel Pharmaceuticals plc in the past 3 months
Rating breakdown
Buy
8 57%
Hold
6 43%
57%
Buy
8 analysts
43%
Hold
6 analysts
0%
Sell
0 analysts
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message